Cardio-fistular Recirculation in Patients With Chronic Heart Failure and Preserved Left Ventricle Ejection Fraction - Trial NCT06394986
Access comprehensive clinical trial information for NCT06394986 through Pure Global AI's free database. This phase not specified trial is sponsored by Moscow Regional Research and Clinical Institute (MONIKI) and is currently Completed. The study focuses on Chronic Kidney Disease 5D,Heart Failure,Heart Failure NYHA Class I,Heart Failure NYHA Class II. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Hemodialysis session
Observational
procedure
Sponsor & Location
Moscow Regional Research and Clinical Institute (MONIKI)
Timeline & Enrollment
N/A
Jun 18, 2018
Feb 18, 2019
Primary Outcome
Change in cardio-fistular recirculation
Summary
This is a single-arm cohort study aimed to evaluate change of arteriovenous fistula volume
 blood flow / cardiac output ratio in patients with chronic heart failure (NYHA I-II classes)
 and with preserved ejection fraction as a result of a hemodialysis session after a long
 interdialysis interval.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06394986
Non-Device Trial